FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression.

Lili Sun, Lili Chen, Hua Zhu, Yumo Li, Clark C Chen, Ming Li

FEBS letters 2021 Jan

filter terms:

The four-and-a-half LIM domain protein 1 (FHL1) plays a key role in multiple cancers. Here, we characterized its role in glioblastoma (GBM), the most common and incurable form of brain cancer. Overexpression of FHL1 promotes growth, migration, and invasion of GBM cells in vivo and in vitro. In contrast, FHL1 silencing by RNAi exhibits the opposite effects. FHL1 interacts with the transcription factor SP1 to upregulate epidermal growth factor receptor (EGFR) expression and activate the downstream signaling cascades, including Src, Akt, Erk1/2, and Stat3, leading to GBM malignancy. FHL1 is highly expressed and positively correlated with EGFR levels in human GBM, particularly those of the classical subtype. Our results suggest that the FHL1-SP1-EGFR axis plays a tumor-promoting role, and highlight the translational potential of inhibiting FHL1 for GBM treatment. © 2020 Federation of European Biochemical Societies.

Citation

Lili Sun, Lili Chen, Hua Zhu, Yumo Li, Clark C Chen, Ming Li. FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression. FEBS letters. 2021 Jan;595(1):85-98